Oncogenic PI3K/AKT promotes the step-wise evolution of combination BRAF/MEK inhibitor resistance in melanoma

por Irvine, Mal, Stewart, Ashleigh, Pedersen, Bernadette, Boyd, Suzanah, Kefford, Richard, Rizos, Helen
Publicado 2018

Clinical significance of intronic variants in BRAF inhibitor resistant melanomas with altered BRAF transcript splicing

por Pupo, Gulietta M., Boyd, Suzanah C., Fung, Carina, Carlino, Matteo S., Menzies, Alexander M., Pedersen, Bernadette, Johansson, Peter, Hayward, Nicholas K., Kefford, Richard F., Scolyer, Richard A., Long, Georgina V., Rizos, Helen
Publicado 2017

Oncogenic B-RAF(V600E) signaling induces the T-box3 transcriptional repressor to repress E-cadherin and enhance melanoma cell invasion

por Boyd, Suzanah C., Mijatov, Branka, Pupo, Gulietta M., Tran, Sieu L., Gowrishankar, Kavitha, Shaw, Heather M., Goding, Colin R., Scolyer, Richard A., Mann, Graham J., Kefford, Richard F., Rizos, Helen, Becker, Therese M.
Publicado 2012

Circulating tumor DNA to monitor treatment response and detect acquired resistance in patients with metastatic melanoma

por Gray, Elin S., Rizos, Helen, Reid, Anna L., Boyd, Suzanah C., Pereira, Michelle R., Lo, Johnny, Tembe, Varsha, Freeman, James, Lee, Jenny H.J., Scolyer, Richard A., Siew, Kelvin, Lomma, Chris, Cooper, Adam, Khattak, Muhammad A., Meniawy, Tarek M., Long, Georgina V., Carlino, Matteo S., Millward, Michael, Ziman, Melanie
Publicado 2015